DrugInformations.org

Treatment For Parkinson’s Examined

Oct 1st 2008Drug InformationParkinson's Disease

The PhD defended by Juan Carlos Gomez-Esteban at the University of the Basque Country analysed the results of the clinical research undertaken at the Movement Disorders Unit at Cruces Hospital since 1998. It involved a study of the most efficacious surgical operations undertaken and pharmaceutical drugs used to treat these disorders as well genetic studies carried out to date. The field of movement disorders is one of the most complex branches of neurology.

More: continued here

Mediterranean Diet Protects Against Major Chronic Diseases

Researchers in Italy found that sticking rigidly to a full Mediterranean diet can help reduce deaths from major chronic diseases like heart disease, cancer, Parkinson’s and Alzheimer’s disease, further bolstering the diet’s reputation as a model of healthy eating characterized by low intake of meat, dairy products and alcohol, but high intake of vegetables, fruits, nuts, olive oil, grains and fish.

More: continued here

Examining The Treatment For Parkinson’s

The PhD defended by Juan Carlos Gomez-Esteban at the University of the Basque Country analysed the results of the clinical research undertaken at the Movement Disorders Unit at Cruces Hospital since 1998. It involved a study of the most efficacious surgical operations undertaken and pharmaceutical drugs used to treat these disorders as well genetic studies carried out to date. The field of movement disorders is one of the most complex branches of neurology.

More: continued here

Discovery Of Protein That Regulates Gene Critical To Dopamine-Releasing Brain Cells

Researchers have identified a protein they say appears to be a primary player in maintaining normal functioning of an important class of neurons - those brain cells that produce, excrete and then reabsorb dopamine neurotransmitters. These molecules command numerous body functions, ranging from management of behavior and mood to control of movement, and one day may hold the key to why and how some people develop Parkinson’s and other brain diseases.

More: continued here

CABASER(R) (Cabergoline) Product Information Update

Pfizer Australia is due to release new safety updates to the Cabaser� (cabergoline) Product Information which will come into effect on November 1, 2008. Ongoing review of clinical studies suggests that fibrosis and valvulopathy are associated with ergot-derived dopamine agonists, including Cabaser (cabergoline) and could be linked to cumulative doses of the medicine.

More: continued here

Parkinson Disease Support Group Brings World Class Conference To Rome, Georgia

The 3rd Annual Southeastern Parkinson Disease Conference will be held at Berry College in Rome, Georgia on November 6 - 8, 2008. Nationally and Internationally recognized experts in their fields will present programs on various aspects of living with Parkinson Disease. Early Registration is $75.

More: continued here

Study Finds Way To Prevent Protein Clumping Characteristic Of Parkinson’s Disease

Researchers at the University of Pennsylvania School of Medicine have identified a protein from a most unlikely source — baker’s yeast — that might protect against Parkinson’s disease. More than a million Americans suffer from Parkinson’s disease, and no treatments are available that fundamentally alter the course of the condition.

More: continued here

Using Plastic Coatings To Help Medical Implants Connect With Neurons

Plastic coatings could someday help neural implants treat conditions as diverse as Parkinson’s disease and macular degeneration. The coatings encourage neurons in the body to grow and connect with the electrodes that provide treatment. Jessica O. Winter, assistant professor of chemical and biomolecular engineering at Ohio State University described the research at the American Chemical Society meeting in Philadelphia.

More: continued here

The University Of Nottingham In The British Midlands Announces Breakthrough In Parkinson’s Disease Research

The British Midlands Development Corporation today announced that scientists at The University of Nottingham have made a crucial breakthrough in the battle to slow or prevent the onset of a very common type of dementia and Parkinson’s disease.

More: continued here